Dr. Antonella Santuccione Chadha

Dr. Antonella Santuccione Chadha is a distinguished medical doctor renowned for her expertise in neuroscience and psychiatry, as well as her leadership in organization management, research, and clinical development. She is the founder and pro bono CEO of the Women’s Brain Foundation, a non-profit organization dedicated to using precision medicine to explore the impact of sex and gender on mental and brain diseases.

In addition to her role at the Women’s Brain Foundation, Dr. Chadha serves as the Vice-President and a board member of Euresearch, a Swiss agency that supports research and innovation activities across Europe. Her leadership and strategic guidance have been instrumental in the success of various start-ups, and she has provided valuable counsel to presidents, CEOs, boards of directors, and junior colleagues.

Dr. Chadha has a diverse professional background, having worked in European universities, pharmaceutical companies such as Roche and Biogen, the Swiss regulatory agency for therapeutic product approval, and policy organizations. She has also served as the chief medical officer and ad-interim CEO of Altoida, a company specializing in digital AI-driven diagnostics for precision neurology. Her leadership roles in these organizations have seen her lead large teams across corporate, academic, and hospital settings. She has successfully managed and coordinated multidisciplinary teams, fostering a collaborative environment that drives innovation and efficiency. Dr. Chadha is also skilled in directly managing junior colleagues and adept at working within complex matrix structures, ensuring effective communication and alignment across different functions and departments.

Her accomplishments have earned her numerous accolades, including being listed among the Top 100 Women in Business in Switzerland since 2018 and being named Woman of the Year in Switzerland in 2019. Dr. Chadha has also received the World Sustainability Award for her contributions to advancing precision medicine and the "Premio Medicina Italia" for her efforts in managing the pandemic. In 2022, she was honored with the Veuve Clicquot Bold Woman Award in Switzerland. More recently, in 2024, she received the “Women Empowering Award” and will be recognized for her contributions to Swiss scientific advancement with the “Katherinenturm” Project.